1229245-21-9

Basic information

• Product Name: 3-bromo-N-cyclopropyl-5-(3-methoxypropyl)-4-methylbenzamide
• Synonyms: 3-bromo-N-cyclopropyl-5-(3-methoxypropyl)-4-methylbenzamide
• CAS NO: 1229245-21-9
• Molecular Weight: 326.233
• Mol File: 1229245-21-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-bromo-N-cyclopropyl-5-(3-methoxypropyl)-4-methylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-N-cyclopropyl-5-(3-methoxypropyl)-4-methylbenzamide(1229245-21-9)
• EPA Substance Registry System: 3-bromo-N-cyclopropyl-5-(3-methoxypropyl)-4-methylbenzamide(1229245-21-9)

Safety Data

• Hazardous Substances Data: 1229245-21-9(Hazardous Substances Data)

Upstream product

• 1229245-22-0 3-bromo-N-cyclopropyl-5-[(1E)-3-methoxyprop-1-en-1-yl]-4-methylbenzamide 
• 1229245-18-4 3-bromo-N-cyclopropyl-5-(3-methoxyprop-1-yn-1-yl)-4-methylbenzamide 
• 1229245-20-8 3-bromo-5-iodo-4-methylbenzoic acid 
• 1229245-19-5 3-bromo-5-(3-methoxyprop-1-yn-1-yl)-4-methylbenzoic acid 
• 7697-26-9 3-bromo-4-methylbenzoic acid 
• 1229245-24-2 3,5-dibromo-N-cyclopropyl-4-methylbenzamide 
• 67973-32-4 3,5-dibromo-4-methylbenzoic acid 

Downstream Products

• 1194488-55-5 N-[3-bromo-5-(3-methoxypropyl)-4-methylbenzyl]cyclopropanamine 
• 1312350-29-0 (3R,4S)-N-[3-bromo-5-(3-methoxypropyl)-4-methylbenzyl]-N-cyclopropyl-4-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-piperidine-3-carboxamide 
• 1312350-26-7 tert-butyl (3R,4S)-3-{[[3-bromo-5-(3-methoxypropyl)-4-methylbenzyl](cyclopropyl)amino]carbonyl}-4-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)piperidine-1-carboxylate 
• 1194491-85-4 N-[3-bromo-5-(3-methoxypropyl)-4-methylbenzyl]cyclopropanamine mesylate 
• 1312350-32-5 (3R,4S)-N-[3-bromo-5-(3-methoxypropyl)-4-methylbenzyl]-N-cyclopropyl-4-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-piperidine-3-carboxamide hydrochloride 
• 1194488-76-0 3-{3-bromo-5-[(cyclopropylamino)methyl]-2-methylphenyl}-1-propanol 

Relevant articles and documents

Convergent kilo-scale synthesis of a potent renin inhibitor for the treatment of hypertension

Process research and development of a synthetic route towards a novel renin inhibitor (1) is described. The highly convergent synthetic route provided 1 in 15% yield on multikilogram scale with a longest linear sequence of 11 steps. The use of catalytic h

3, 4 - SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS

The present invention relates to 3,4-substituted piperidinyl - based renin inhibitor compounds bearing at 4-position lsoqumolone and having the Formula (I) : The invention further relates to pharmaceutical compositions containing said compounds, as well a